Drug Channels

MARCH 31, 2025

Threes still company in the world of pharmacy benefit managers. Below, we break down the latest market share data from Drug Channels Institute (DCI), explore the developments driving these changes, and examine what they signal for the future of the PBM landscape. P.S. Special launch pricing on our new 2025 Economic Report on U.S.

Pharmacy 98

Pharmacy Marketing Drugs 98

Drug Channels

JUNE 19, 2025

This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. Click here to see the original post from April 2025. drug channels. drug channels. All rights reserved. This Feed is for personal non-commercial use only.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Drugs Research 52

Drug Channels

JANUARY 14, 2025

During my recent Drug Channels Outlook 2025 video webinar, I tackled a wide range of crucial topicsincluding the controversial 340B Drug Pricing Program. As I explain in this video excerpt, we may finally see reform of this rapidly expanding program. All rights reserved. This Feed is for personal non-commercial use only.

Pharmacy 52

Pharmacy Hospitals Marketing Drugs 52

Drug Channels

FEBRUARY 18, 2025

Small pharmacies have ghosted Medicare Part Ds preferred networksno farewell party, no breakup text, just a quiet exit. A few months ago , DCI highlighted how the largest pharmacy chains are participating as preferred cost sharing pharmacies in the 2025 stand-alone prescription drug plan (PDP) networks.

Pharmacy 52

Pharmacy Independent Pharmacies Marketing Drugs 52

Drug Channels

MAY 20, 2025

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: Whats Next for Retail Pharmacy: Data, Debate, and Disruption This event will be broadcast live on: Friday, June 20, 2025 12:00 p.m. to 1:30 p.m.

Pharmacy 75

Pharmacy Pharmaceuticals Marketing Drugs 75

Drug Channels

MARCH 4, 2025

Fein, president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCIs new live video webinar: PBM Industry Update: Trends, Challenges, and What's Ahead This event will be broadcast live on Friday, April 4, 2025, from 12:00 p.m. Drawing from the brand-new 2025 Economic Report on U.S.

Pharmacy 98

Pharmacy Specialty Pharmacies Marketing Drugs 98

Drug Channels

APRIL 8, 2024

I am pleased to announce the inaugural Drug Channels Leadership Forum ! This unique, new event will be held from March 17 to 19, 2025, at the Turnberry Resort and Spa in Miami. Thanks to DCI’s partnership with HMP Global, we can bring this novel event to the drug channels community. Click here to request an invitation.

Pharmacy 97

Pharmacy Drugs Government Pharmaceuticals 97

Drug Channels

APRIL 1, 2025

Click here to see the original post from January 2025. For 2025, the three largest pharmacy benefit managers (PBMs)Caremark (CVS Health), Express Scripts (Cigna), and Optum Rx (United Health Group)have again each excluded hundreds of drugs from their standard formularies. You can find our updated counting below.

Biosimilars 52

Biosimilars Pharmacy Production Drugs 52

Drug Channels

JUNE 16, 2025

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. Click here to see the original post from March 2025. Next week, Drug Channels Institute (DCI) will release our 2025 Economic Report on U.S. All rights reserved.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Marketing Drugs 52

FDA Law Blog: Biosimilars

FEBRUARY 18, 2025

Hull A recent DEA decision revoking the registration of a Louisiana pharmacy sheds light on the Agencys approach to crediting one experts testimony over that of another expert during an administrative hearing. In Neumanns Pharmacy, LLC , 90 Fed. By Andrew J.

Testimonials 69

Testimonials Pharmacy Government Drugs 69

Drug Channels

MAY 21, 2025

The Inflation Reduction Act (IRA) is triggering increases in Medicare beneficiaries spending on their Part B drugs. We find that a growing number of Part B drugs now have inflation-adjusted coinsurance rates that are rising, not falling. Retail Pharmacy Update 2025: Data, Debate, and Disruption. Fein and Antonio Ciaccia.

Pharmacy 52

Pharmacy Drugs 52

Drug Channels

JUNE 10, 2025

The 340B Drug Pricing Program has emerged as a growing source of profits for pharmacies and pharmacy benefit managers (PBMs). pharmacy industry—function as contract pharmacies for the hospitals and federal grantees that participate in the 340B program. It was meant to be part of patient care.” Fein, Ph.D.,

Pharmacy 59

Pharmacy Marketing Hospitals Drugs 59

Drug Channels

JUNE 17, 2025

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. Click here to see the original post from March 2025. Three’s still company in the world of pharmacy benefit managers. All rights reserved.

Pharmacy 52

Pharmacy Marketing Drugs Research 52

Drug Channels

MARCH 18, 2025

I am pleased to announce that Drug Channels Institutes new 2025 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers is now available for purchase and immediate download. drug pricing, reimbursement, and dispensing system. prescription drug channels. Pharmacies and Pharmacy Benefit Managers.

Pharmacy 52

Pharmacy Specialty Pharmacies Licensing Licensing 52

Drug Channels

MAY 28, 2025

Whats Next for Retail Pharmacy: Data, Debate, and Disruption. Dont miss DCIs first webinar of the year on June 20, 2025 (12:001:30 p.m. Well unpack the good, the bad, and the ugly of the pharmacy industryand explore what it means for you. ET), featuring Dr. Adam J. Fein and Antonio Ciaccia. All rights reserved.

Pharmacy 52

Pharmacy Drugs International 52

Drug Target Review

JUNE 11, 2025

Drug development is plagued by complex challenges, but multimodal AI is unlocking new opportunities. By integrating diverse data sources – from genomics to clinical insights – this approach is accelerating drug discovery, improving patient stratification and boosting success rates.

Drugs 64

Drugs Clinical Trials Drug Development Pharmaceuticals 64

Drug Channels

DECEMBER 13, 2024

This week, Im rerunning some popular posts while I prepare for todays Drug Channels Outlook 2025 live video webinar. (If As you will see below, CMS projects that outpatient prescription drugs dispensed by retail and mail pharmacies will remain a small share of total U.S. If you sign up before 12 p.m. healthcare spending.

Government 98

Government Specialty Pharmacies Pharmacy Drugs 98

Drug Channels

JULY 8, 2025

The 2025 launch of biosimilars to Johnson & Johnson’s Stelara (ustekinumab) marks another turning point in pharmacy benefit dynamics. But unlike the chaotic rollout of Humira biosimilars, pharmacy benefit managers (PBMs) came prepared. As always, with great pricing power comes great responsibility. All rights reserved.

Biosimilars 52

Biosimilars Pharmacy Marketing Drugs 52

Drug Channels

MAY 30, 2025

Aaron introduces us to GoodRx Community Link , a new offering from GoodRx that allows independent pharmacies to contract directly with GoodRx. To learn about GoodRx Community Link, register for GoodRxs free webinar on either June 3, 2025, or June 4, 2025. Both webinars will be held at 11:00 a.m. Read on for Aarons insights.

Pharmacy 85

Pharmacy Independent Pharmacies Drugs 85

Drug Channels

APRIL 16, 2025

Drug Channels Institutes (DCIs) latest analysis reveals that PBM-affiliated specialty pharmacies continue to dominate the dispensing of specialty drugs. DCI has identified nearly 1,900 dispensing locations with specialty pharmacy accreditation. Click here to share your thoughts with the Drug Channels LinkedIn community.

Specialty Pharmacies 40

Specialty Pharmacies Pharmacy Marketing Drugs 40

FDA Law Blog: Biosimilars

MAY 19, 2025

Attorneys Office, Northern District of Illinois, April 21, 2025. Prescriptions of drugs or drug combinations that are frequently sought by individuals known to abuse or misuse prescription drugs, including the combination of an opioid, a benzodiazepine and a muscle relaxant, known as the trinity. 81, 86, 251.

Doctors 64

Doctors Pharmacy Drugs Government 64

Drug Channels

APRIL 27, 2025

Spring has officially arrived at Drug Channels' worldwide headquarters in beautiful downtown Philadelphia. So, scurry over to this months curated crop of noteworthy news: Amazon Pharmacy is still coming for retail pharmacy Express Scripts revives its long-lost drug trend report Prior authorization gold cards: Progress or peril?

Pharmacy 52

Pharmacy Drugs 52

Drug Channels

DECEMBER 12, 2024

This week, Im rerunning some popular posts while I prepare for tomorrows Drug Channels Outlook 2025 live video webinar. Time for DCIs annual update on the channels for provider-administered drugs. drug channels. Read more 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Specialty Pharmacies 52

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 52

Fierce BioTech

DECEMBER 23, 2024

First-in-Human, Drug-Drug Interaction, Food Effect, Bioequivalence, etc.), and often require consistent batches of drug product be administered to groups of research participants within a short timeframe, early phase studies present unique challenges for drug developers not typically experienced in later stages of development.

Pharmacy 52

Pharmacy Trials Clinical Trials Clinical Development 52

Drug Channels

MARCH 26, 2025

Spring has officially arrived in sunny downtown Philadelphiathe proud home base of Drug Channels. As you can see on the right, we celebrated in Miami at the Drug Channels Leadership Forum. on April 4, 2025, from 12:00 p.m. Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company.

Biosimilars 52

Biosimilars Pharmacy Drugs 52

Drug Channels

APRIL 4, 2025

Click here to see the original post from January 2025. It's time for Drug Channels annual examination of U.S. brand-name drug pricing. For 2024, average brand-name drugs list prices grew by only 2.3%. But for the first time in years, I can foresee a time when SpongeBob SquarePants will move on from Drug Channels.

Pharmacy 52

Pharmacy Drugs Production 52

Drug Channels

OCTOBER 21, 2024

Informa Connect’s Trade and Channel Strategies December 10-12, 2024 at the W Hotel in Philadelphia, PA Drug Channels readers save 10% with code 24DC10 * Pharmacy and distribution models are growing increasingly complex. Is my organization haemorrhaging money to stay afloat with the shift to alternative distribution and pharmacy models?

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Marketing Compliance 98

Drug Channels

MAY 8, 2025

Mike shares key takeaways on patient access and affordability from CoverMyMeds 2025 Medication Access Report. He focuses on the systemic fragmentation that exists across payers, providers, and pharmacies. Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.

Pharmacy 59

Pharmacy Treatment Drugs 59

Drug Channels

MARCH 21, 2025

Greg discusses some of the challenges manufacturers face with product commercialization, patient access and adherence, and negotiating partnerships with pharmacy benefit managers (PBMs). Read more 2006-2025 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Read on for Greg's insights.

Pharmacy 98

Pharmacy Production Drugs 98

Drug Channels

JUNE 3, 2025

Its time for Drug Channels annual look at pharmacist salaries and employment. There was more bad news, as employment in retail pharmacies and drugstores dropped by 8,500 positions in 2024, following a drop of 4,800 positions in 2023. Employment in mass merchants and supermarkets with pharmacies increased. Dr. Adam J.

Hospitals 52

Hospitals Pharmacy Marketing Drugs 52

Drug Channels

JULY 11, 2025

Today’s guest post comes from Lindsay Reel, VP of Pharmacy Practice & Specialty Solutions at EVERSANA. In this article, Lindsay shares a pharmacist’s firsthand perspective on the growing complexity of patient access and the limitations of traditional pharmacy models. Read on for Lindsay’s insights. All rights reserved.

Pharmacy 52

Pharmacy Therapies Drugs 52

Drug Channels

DECEMBER 17, 2024

Its been a huge year for Drug Channels Institute (DCI). Thanks to our new friends at HMP, we will hold the Drug Channels Leadership Forum. This landmark event will take place in March 2025 in Miami. (If Once again, I thank you, dear readers, for welcoming Drug Channels into your inboxes, browsers, and apps. No worries!

Pharmacy 40

Pharmacy Independent Pharmacies Drugs 40

Drug Channels

DECEMBER 3, 2024

Minnesota just released the industry‘s first ever mandated financial report on the 340B Drug Pricing Program. Below, I do a wicked deep dive into the data and highlight crucial implications about spending, profits, pharmacies, plans, patients, program integrity, and more. It’s time to pay attention to the money behind the 340B curtain.

Pharmacy 52

Pharmacy Doctors Drugs Hospitals 52

Drug Channels

MAY 16, 2025

Divya shares new GoodRx data showing that out-of-pocket costs at the pharmacy counter remain a primary barrier to medication adherence. To learn about GoodRxs prescription abandonment solutions, download Reduce Rx Abandonment at the Pharmacy. Read on for Divyas insights. Read on for Divyas insights. All rights reserved.

Pharmacy 52

Pharmacy Marketing Drugs 52

Drug Channels

APRIL 15, 2025

Whether you're building trust with customers, launching new products, or guiding internal teams, understanding the economic forces that shape drug distribution, reimbursement, and pricing is essential. Understand reimbursement dynamics, cost estimation methods, and how profitability varies across drug types and dispensing models.

Specialty Pharmacies 52

Specialty Pharmacies Pharmaceuticals Pharmacy Licensing 52

The Pharma Data

JUNE 6, 2025

CSOs allow pharmaceutical firms to scale sales operations rapidly , particularly during drug launches , geographic expansions , product lifecycle extensions , and co-promotion agreements. These developments demand a highly skilled, therapeutically trained, and compliance-conscious salesforce —precisely what leading CSOs offer. In the U.S.,

Pharmaceutical Companies 40

Pharmaceutical Companies Compliance Pharmaceuticals International 40

Drug Channels

JANUARY 13, 2025

The inaugural Drug Channels Leadership Forum (DCLF) is coming soon! This exclusive event will be held from March 17 to 19, 2025, at the Turnberry Resort and Spa in Miami. drug channels. Speakers and panelists include top industry executives and subject matter experts from throughout the drug channel.

Pharmacy 52

Pharmacy Drugs Pharmaceuticals 52